Literature DB >> 14675236

Therapeutic options for esophageal cancer.

Simon Law1, John Wong.   

Abstract

Options for the treatment of esophageal cancer used to be very limited, with surgical resection and radiotherapy methods aimed at both cure or palliation, and, in those unfortunate patients with severe dysphagia, intubation with a plastic prosthesis to restore esophageal luminal patency. Progress in the management of this cancer in the past two decades includes refinement in surgical techniques and perioperative care, better radiological staging methods, enhanced means of planning and delivering radiotherapy, multimodality treatments, and better designs in esophageal prosthesis. For individual patients, a stage-directed therapeutic plan can be used. Long-term survival, however, remains suboptimal for this deadly disease. The current review presents an overview of the commonly employed therapeutic options for esophageal cancer at the beginning of the 21st century.

Entities:  

Mesh:

Year:  2004        PMID: 14675236     DOI: 10.1111/j.1440-1746.2004.03154.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden.

Authors:  Pernilla Viklund; Mats Lindblad; Ming Lu; Weimin Ye; Jan Johansson; Jesper Lagergren
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  The use of self-expanding stents in esophageal and gastroesophageal junction cancer palliation: a meta-analysis and meta-regression analysis of outcomes.

Authors:  George Sgourakis; Ines Gockel; Arnold Radtke; Georgia Dedemadi; Konstantinos Goumas; Sofia Mylona; Hauke Lang; Achilleas Tsiamis; Constantine Karaliotas
Journal:  Dig Dis Sci       Date:  2010-05-04       Impact factor: 3.199

3.  Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer.

Authors:  Anna Agnieszka Klimczak-Bitner; Radzisław Kordek; Jan Bitner; Jacek Musiał; Janusz Szemraj
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

4.  Esophageal adenocarcinoma arising from Barrett's dysplasia: a case report of double occurrence and prolonged survival after chemotherapy.

Authors:  Hemender S Vats; Tarit K Banerjee; Jeffrey Resnick; Qaseem Khan
Journal:  Clin Med Res       Date:  2006-09

5.  Thoracoscopic and laparoscopic esophagectomy: initial experience and outcomes.

Authors:  D J Martin; J R Bessell; A Chew; D I Watson
Journal:  Surg Endosc       Date:  2005-10-17       Impact factor: 4.584

6.  Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease.

Authors:  Daniel King-Hung Tong; Dora Lai Wan Kwong; Simon Law; Kam Ho Wong; John Wong
Journal:  J Gastrointest Surg       Date:  2008-08-14       Impact factor: 3.452

7.  Minimally invasive surgery for esophageal cancer - benefits and controversies.

Authors:  Grzegorz Wallner; Witold Zgodziński; Wioletta Masiak-Segit; Tomasz Skoczylas; Andrzej Dąbrowski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.